A novel antiviral lncRNA, EDAL, shields a T309 O-GlcNAcylation site to promote EZH2 lysosomal degradation
Baokun Sui,Dong Chen,Wei Liu,Qiong Wu,Bin Tian,Yingying Li,Jing Hou,Shiyong Liu,Juan Xie,Hao Jiang,Zhaochen Luo,Lei Lv,Fei Huang,Ruiming Li,Chengguang Zhang,Yuling Tian,Min Cui,Ming Zhou,Huanchun Chen,Zhen F. Fu,Yi Zhang,Ling Zhao
DOI: https://doi.org/10.1186/s13059-020-02150-9
IF: 17.906
2020-09-01
Genome Biology
Abstract:Abstract Background The central nervous system (CNS) is vulnerable to viral infection, yet few host factors in the CNS are known to defend against invasion by neurotropic viruses. Long noncoding RNAs (lncRNAs) have been revealed to play critical roles in a wide variety of biological processes and are highly abundant in the mammalian brain, but their roles in defending against invasion of pathogens into the CNS remain unclear. Results We report here that multiple neurotropic viruses, including rabies virus, vesicular stomatitis virus, Semliki Forest virus, and herpes simplex virus 1, elicit the neuronal expression of a host-encoded lncRNA EDAL. EDAL inhibits the replication of these neurotropic viruses in neuronal cells and rabies virus infection in mouse brains. EDAL binds to the conserved histone methyltransferase enhancer of zest homolog 2 (EZH2) and specifically causes EZH2 degradation via lysosomes, reducing the cellular H3K27me3 level. The antiviral function of EDAL resides in a 56-nt antiviral substructure through which its 18-nt helix-loop intimately contacts multiple EZH2 sites surrounding T309, a known O -GlcNAcylation site. EDAL positively regulates the transcription of Pcp4l1 encoding a 10-kDa peptide, which inhibits the replication of multiple neurotropic viruses. Conclusions Our findings show that a neuronal lncRNA can exert an effective antiviral function via blocking a specific O -GlcNAcylation that determines EZH2 lysosomal degradation, rather than the traditional interferon-dependent pathway.
genetics & heredity,biotechnology & applied microbiology